TABLE E1.
Day after transplantation | Reversible | Fatal | |
---|---|---|---|
Patient 1 | |||
Infection | |||
EBV reactivation | + 159 | Yes | No |
Recurrent pneumonia | + 1464 | Yes | No |
Bleeding (coagulopathy associated with colitis) | +2765 | Yes | No |
CV | |||
Catheter-associated thrombus | + 159 | Yes | No |
SVT | + 159 | Yes | No |
GI | |||
Recurrence of colitis | +2756 | Yes | No |
Heme | |||
Lymphopenia | +2249 | No | No |
Hypogammaglobulinemia | + 1611 | No | No |
Secondary graft loss | + 30 | No | No |
Patient 2 (first transplantation) | |||
Infection | |||
S parasanguis bacteremia | −2 | Yes | No |
CMV viremia | + 19 | Yes | No |
Secondary graft loss | + 33 | No | No |
Patient 2 (second transplantation) | |||
Renal/GU | |||
Drug-associated nephropathy | + 28 | Yes | No |
GvHD | + 30 | Yes | No |
Patient 3 | |||
GvHD | + 16 | Yes | No |
Patient 4 | |||
Heme | |||
Severe thrombocytopenia | +5 | Yes (+490) | No |
Lymphopenia | + 30 | No | no |
Hypogammaglobulinemia | + 304 | No | No |
Secondary graft loss | + 120 | No | No |
Death (sepsis, pneumonia) | +779 | No | Yes |
Patient 5 | |||
Infection | |||
CMV | Before transplantation | No | +7 |
GvHD | + 10 | Yes | No |
Death | + 12 | ||
Patient 6 (first transplantation) | |||
Infection | |||
Fungal pneumonia | + 24 | Yes | No |
BK virus reactivation | + 24 | No | No |
Patient 6 (second transplantation) | |||
Infection | |||
Adenovirus reactivation | + 2 | Yes | No |
Cryptosporidium gut | + 20 | Yes | No |
Fungal pneumonia | + 74 | No | Yes |
GvHD | + 17 | Yes | No |
Death | +4 mo | No | Yes |
Patient 7: Turkey | |||
Infection | |||
Mycotic aneurysm | Before transplantation | No | Yes |
Bleeding | + 88 | No | Yes |
Death | +3 mo | ||
Patient 8 | |||
CV | |||
Cardiomyopathy | + 1 | No | Yes |
Death | +3 | ||
Patient 9 (first transplantation) | |||
Infection | |||
S mitis sepsis | + 22 | Yes | No |
Hemophagocytosis | +25 (first) | No | No |
Secondary graft loss | +45 | No | Yes |
Patient 9 (second transplantation) | |||
Infection | + 14 | No | Yes |
Adenovirus viremia | +35 | ||
CV | |||
Cardiac/pleural effusion | + 21 | No | Yes |
GI | |||
Ascites | +21 | No | Yes |
Renal/GU | |||
Adenovirus cystitis | +29 | No | No |
Secondary graft loss | +32 | No | Yes |
Patient 9 (third transplantation) | |||
Bleeding | + 17 | No | Yes |
GI | |||
Pancreatitis | + 13 | Yes | No |
Death | + 109 | No | Yes |
Patient 10: Japan | |||
CV | |||
TMA | +20 | Yes | No |
Lung | |||
Acute pulmonary edema | + 4 | Yes | No |
GI | |||
Recurrent pancreatitis | −1, +32, +42, +53, +58, +63 | Yes | No |
Patient 11 | |||
Infection | |||
Pulmonary aspergillosis | + 150 | Yes | No |
GI | |||
Hemorrhagic bleeding | +30 | Yes | No |
Renal/GU | |||
Hemorrhagic cystitis | + 18, +120 | Yes | No |
Heme | |||
Lymphopenia | +50 | Yes | No |
Hypogammaglobulinemia | +50 | ||
GvHD | |||
Skin | + 7 | Yes | No |
GI | + 17 | Yes | No |
Patient 12: Canada | |||
Lung | |||
Pulmonary hemorrhage | +20 | No | Yes |
GI | |||
GI bleeding | + 13 | Yes | No |
Renal/GU | |||
Renal failure | +21 | No | Yes |
Other | |||
TEN | + 16 | No | Yes |
GvHD | + 12 | No | No |
Death | +42 | No | Yes |
Patient 13: United Kingdom | |||
GvHD | +50 | Yes | No |
Patient 14 | |||
Infection | |||
CMV | +31 | Yes | No |
Candidiasis | +72 | Yes | No |
Sepsis | +214 | Yes | No |
Secondary graft loss | + 28, +90 | No | No |
Death (sepsis) | +410 | No | Yes |
Patient 15 | |||
Infection | |||
Pneumonia | +52, +300 | Yes, no | No, yes |
GI | |||
Increased transaminase levels | + 150 | No | No |
Heme | |||
Severe thrombocytopenia | + 150 | No | No |
Secondary graft loss | + 130 | No | No |
Death | +10 mo | No | Yes |
CV, Cardiovascular; CVM. cytomegalovirus; GI, gastrointestinal; GU, genitourinary; SVT, supraventricular tachycardia; TEN, toxic epidermal necrolysis; TMA, thrombotic microangiopathy.